Koers Edwards Lifesciences Corporation London S.E.
Aandelen
0REN
US28176E1082
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
77,56 CHF | +5,72% | -.--% | -.--% |
Omzet 2024 * | 6,56 mld. 5,97 mld. 6,04 mld. | Omzet 2025 * | 7,2 mld. 6,56 mld. 6,63 mld. | Marktkapitalisatie | 54,1 mld. 49,27 mld. 49,84 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,62 mld. 1,48 mld. 1,49 mld. | Nettowinst (verlies) 2025 * | 1,86 mld. 1,7 mld. 1,72 mld. | EV/omzet 2024 * | 7,99 x |
Nettoliquiditeiten 2024 * | 1,7 mld. 1,55 mld. 1,56 mld. | Nettoliquiditeiten 2025 * | 2,89 mld. 2,63 mld. 2,66 mld. | EV/omzet 2025 * | 7,11 x |
K/w-verhouding 2024 * |
33,8
x | K/w-verhouding 2025 * |
29,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 91,59% |
Recentste transcriptie over Edwards Lifesciences Corporation
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 56 | 01-01-15 | |
Scott Ullem
DFI | Director of Finance/CFO | 57 | 01-01-14 |
Todd Brinton
CTO | Chief Tech/Sci/R&D Officer | - | 01-02-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leslie Heisz
BRD | Director/Board Member | 63 | 05-07-16 |
Chairman | 67 | 13-11-14 | |
Steven Loranger
BRD | Director/Board Member | 72 | 16-03-16 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,19% | 227 mld. | |
+15,25% | 198 mld. | |
+18,11% | 142 mld. | |
+31,30% | 111 mld. | |
+1,56% | 64,16 mld. | |
+5,12% | 51,41 mld. | |
+10,72% | 45,32 mld. | |
+5,04% | 37,32 mld. | |
+26,71% | 32,13 mld. |